ADMA Biologics Inc. (ADMA)
20.95
1.55 (7.99%)
At close: Apr 14, 2025, 3:59 PM
21.16
1.04%
Pre-market: Apr 15, 2025, 04:03 AM EDT
ADMA Biologics Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|
| ADMA BioManufacturing Segment Revenue | 113.09M | 80.11M | 51.82M | 59.76M | 49.58M |
| ADMA BioManufacturing Segment Revenue Growth | +41.16% | +54.60% | -13.29% | +20.54% | n/a |
| Plasma Collection Centers Segment Revenue | 7.45M | 1.78M | 488.76K | 326.35K | 7.3M |
| Plasma Collection Centers Segment Revenue Growth | +319.43% | +263.37% | +49.77% | -95.53% | n/a |
| Corporate Segment Revenue | 36K | 36K | n/a | 35.71K | 35.71K |
| Corporate Segment Revenue Growth | 0.00% | n/a | n/a | 0.00% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 |
|---|---|
| United States Revenue | 146.43M |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 18.56M | 17.55M | 16.64M | 16.22M | 14.73M | 14.25M | 14.51M | 13.89M | 12.89M | 11.97M | 13.7M | 11.7M | 10.73M | 10.44M | 10.03M | 9.3M | 9.12M | 8.7M | 7.93M | 7.03M | 7.2M | 6.09M | 5.6M | 7.14M | 5.36M | 5.01M | 5.01M | 5.18M | 4.2M | 4.44M | 4.28M | 3.28M | 1.78M | 1.72M | 1.71M | 1.88M | 2.08M | 1.44M | 1.35M |
| Selling, General, and Administrative Revenue Growth | +5.75% | +5.44% | +2.61% | +10.15% | +3.36% | -1.82% | +4.44% | +7.77% | +7.71% | -12.62% | +17.11% | +9.05% | +2.77% | +4.03% | +7.89% | +2.03% | +4.75% | +9.71% | +12.80% | -2.29% | +18.26% | +8.77% | -21.58% | +33.23% | +6.97% | +0.04% | -3.46% | +23.57% | -5.41% | +3.70% | +30.27% | +84.56% | +3.19% | +0.95% | -9.37% | -9.33% | +44.57% | +6.79% | n/a |
| Research and Development Revenue | 412K | 560K | 450K | 445.49K | 595.9K | 1.4M | 855.35K | 1.07M | 1.04M | 873.39K | 624.11K | 728.99K | 770.56K | 1.16M | 987.65K | 1.01M | 1.71M | 1.66M | 1.53M | 464.82K | 491.4K | 516.99K | 870.63K | -144.92K | 1.32M | 1.47M | 1.28M | 1.86M | 1.81M | 1.36M | 1.19M | 583.37K | 1.68M | 3.4M | 2.03M | 2M | 2.11M | 1.51M | 1.4M |
| Research and Development Revenue Growth | -26.43% | +24.44% | +1.01% | -25.24% | -57.53% | +64.06% | -20.38% | +3.11% | +19.30% | +39.94% | -14.39% | -5.39% | -33.51% | +17.34% | -2.55% | -40.68% | +3.14% | +8.35% | +228.89% | -5.41% | -4.95% | -40.62% | -700.77% | -111.00% | -10.52% | +14.85% | -31.25% | +2.77% | +33.54% | +13.89% | +104.45% | -65.22% | -50.67% | +67.67% | +1.55% | -5.43% | +40.21% | +7.43% | n/a |